GlassScriptPhysician profile
Bridget A Keast
NPI 1356302947
$1,973.55
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,135 · 2022: $839.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $302.19 | 2021-2022 | |
| Abbvie INC. | $274.79 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.57 | 2021-2022 | |
| Clarus Therapeutics INC. | $141.60 | 2021 | |
| Novo Nordisk INC | $118.57 | 2021-2022 | |
| Boston Scientific Corporation | $112.68 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $111.42 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $102.41 | 2021-2022 | |
| Antares Pharma, INC. | $98.92 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $92.30 | 2021 | |
| Glaxosmithkline, LLC. | $85.87 | 2022 | |
| Janssen Pharmaceuticals, INC | $76.95 | 2021-2022 | |
| Lilly USA, LLC | $71.48 | 2021-2022 | |
| Amgen INC. | $52.46 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $45.78 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $34.54 | 2021-2022 | |
| Genentech USA, INC. | $27.27 | 2021-2022 | |
| Almatica Pharma LLC | $27.19 | 2021 | |
| Nestle Healthcare Nutrition INC. | $18.56 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Keast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.